Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Methylene Blue as a Third-line Vasopressor in Septic Shock to Maintain Hemodynamics

NCT04089072 is registered in ClinicalTrials.gov with Carilion Clinic as lead sponsor.

NCT NCT04089072
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04089072 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Methylene Blue as a Third-line Vasopressor in Septic Shock to Maintain Hemodynamics
Lead sponsor
Carilion Clinic
Phase
Phase 2
Overall status
Unknown status
Start date
December 1, 2019
Completion date
November 1, 2024
Enrollment
250 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

septic shock